medisourceasia.com

Industry News


About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

Imported Non-Sterile Medical Devices Meant For Sterile Use Need Mandatory Registration

The Central Drugs Standard Control Organisation (CDSCO) has made it clear that all imported non-sterile medical devices, if meant to be used as sterile devices in the country, are subjected to mandatory registration. The clarification comes after it was found that many medical devices as imported as non-sterile and later sterilized by hospitals before use. The clarification would ensure that all such devices, especially orthopaediac devices come under the purview of regulatory mechanism.

According to the CDSCO clarification, the matter was examined by an expert committee, which felt that all medical devices if the end use is after sterilization should come under registration requirement and import license as per the Drugs and Cosmetics Rules. The committee also stated that 'batch release certificate' will only be required for those devices, which contain biological products of animal and human origin.

The national level study, commissioned by the Union Ministry of Health and Family Welfare had highlighted the importance of comprehensive regulation of medical devices. The study had called for the preparation of an inventory of products and product groups of various medical devices and equipment that are available in the market. It had also mentioned that the regulation of medical devices is an excellent opportunity for the generation of revenue for the department. The licensing would bring in revenue, apart from ensuring safe and quality healthcare for the general population, it had noted.

It is felt that majority of medical devices are still outside the purview of mandatory registration. The study had recommended regulation of import of devices through import licensing, registration etc., certification of testing laboratories for quality control, pre-market certification, surveillance and notification, enforcement and post marketing follow up (leading to even recall of products) for improving the quality of such products.

(Ref : Chronicle Pharmabiz dated September 28, 2006)


Next

Other News

Medtronic new product for diabetics
Baxter Inc Aligns Indian Operations
Space Hospitals To Widen Telemedicine Services Throughout India
Dr. M. Venkateswarulu Takes Charge As Drugs Controller of India (DCGI)
HLL to venture into vaccine manufacturing, sets sales target of Rs.1000 cr by 2010
India, China To Account For 25 Percent Global Analytical Equipment Market By 2007
Plastindia Foundation: New Team of Office Bearers for the term 2006 – 2009

Archives

Advertisement

 

 


Back | Back To Top | Previous | Next